Substituted aryl-cycloalkanes, and use thereof as anticancer...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 49/84 (2006.01) A61K 31/122 (2006.01) A61K 31/136 (2006.01) A61P 35/00 (2006.01) C07C 49/825 (2006.01) C07C 225/22 (2006.01)

Patent

CA 2469349

The invention concerns products of formula (I), wherein: A represents a saturated or partly saturated cyclic hydrocarbon, optionally substituted; X is selected from the group consisting of O, N-O(R2); Ar¿1? represents a substituted phenyl ring; and Ar¿2? is selected from the group consisting of certain substituted phenyl rings or nitrogenous heterocycles. Said products are useful as anticancer agents, in particular as tubulin polymerization inhibitors.

Les produits répondant à la formule (I) dans laquelle: - A représente un hydrocarbure cyclique saturé ou partiellement insaturé, éventuellement substitué, - X est sélectionné dans le groupe constitué par O, N-O-(R2), - Ar1 représente un premier noyau phényle, substitué, et Ar2 est sélectionné dans le groupe constitué par certains noyaux phényles substitués ou hétérocycles azotés, sont utiles comme agents anticancéreux, en particulier comme inhibiteurs de polymérisaion de la tubuline.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted aryl-cycloalkanes, and use thereof as anticancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted aryl-cycloalkanes, and use thereof as anticancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aryl-cycloalkanes, and use thereof as anticancer... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1596342

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.